Skip to main content

Cath

Complete Angiography Cases:

  1. Cath Case 01: A 33y old Male with NSTEMI

  2. Cath Case 02: A 50y old female with Non-ST Elevation MI and 30% LVEF on echo

 

Cardiac Cath MOCK Exam:


 

Cath Library:

  1. Spade shaped Left Ventricle in Apical variant of Hypertrophic Cardiomyopathy (or Yamaguchi HCM) 
  2. Superior Mesenteric Artery (SMA) stenosis corrected with balloon angioplasty
  3. Left Ventricular (LV) mid cavity obstruction on Ventriculogram
  4. ASD Device Embolization Rescued with Snare
  5. Ligation of MAPCAs (Major Aortopulmonary Collateral Arteries)
  6. Coarctation of the Aorta on Angiogram (Aortogram)
  7. Clot in Left Main Stem (LMS) and Left Circumflex artery (LCX)
  8. Air in Left Ventricle (LV)
  9. Aberrant origin of LAD and LCX from RCA
  10. Pulmonary Stenosis (PS) on ventriculography
  11. Severe Aortic Regurgitation (AR) on Ventriculogram
  12. Severe Mitral Regurgitation (MR) on Ventriculogram
  13. Patent ductus arteriosus (PDA)  
  14. Left Ventricular (LV) aneurysm on ventriculogram  
  15. Dissection of Right coronary artery (RCA)  
  16. Disc thrombosis of a Mitral Valve (MV) prosthesis  
  17. Anomalous Right coronary artery (RCA) originating from left main stem
  18. Coronary wire in LAD with LAD perforation
  19. Bileaflet tilting disc mechanical prosthesis
  20. Moderate disease in mid-distal LMS, Clot in distal LMS, Clot in proximal LCX
  21. RCA continues as LCX which then continues as LAD (Aberrancy)
  22. Pulmonary Artery to Left Atrium Fistula
  23. Right Coronary Artery (RCA) originating from mid portion of Left Anterior descending artery (LAD)

Pressure Tracings:

  1. Identify the labelled curves and name the pathology shown in this pressure tracing
  2. What three hemodynamic findings are seen during this coronary injection? 


Keep visiting for New cases 

Comments

Popular posts from this blog

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 ESC Guidelines on INR Targets in Mechanical Valves

  2025 ESC Guidelines on INR Targets in Mechanical Valves INR Targets in Patients With Mechanical Heart Valves Updated, guideline-oriented review Mechanical heart valves are inherently thrombogenic and require lifelong anticoagulation. Vitamin K antagonists, particularly warfarin, remain the standard therapy. The international normalized ratio (INR) is used to guide anticoagulation intensity and must be individualized based on valve type, valve position, and patient-related thromboembolic risk factors. Subtherapeutic INR increases the risk of valve thrombosis and systemic embolism, whereas excessive anticoagulation increases bleeding risk. Why INR control is critical Mechanical valves promote thrombosis due to non-physiological blood flow, high shear stress, and continuous contact between blood and artificial surfaces. These prothrombotic mechanisms persist for life. Direct oral anticoagulants are contraindicated in mechanical valves; therefore, VKAs remain mandatory. The goal of I...